Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000264642

Medchemexpress LLC Otaplimastat | 1176758-04-5 | 98.1% | 534.61 g/mol | C28H34N6O5 | 5 MG
SDP

Catalog No. 5000264642
Encompass_Preferred

Otaplimastat is a research-grade small-molecule matrix metalloproteinase (MMP) inhibitor supplied as a solid powder for laboratory research. It has molecular formula C28H34N6O5 and a molecular weight of 534.61 g/mol. The material is provided at high purity and is intended for research use only (not for human or veterinary use).

  • High purity (98.1%) suitable for research applications.
  • Molecular weight 534.61 g/mol.
  • Chemical formula C28H34N6O5.
  • Available in small pack sizes, including 5 mg.
  • Supplied as a solid powder for easy handling.
  • Intended for research use only; not for human or veterinary use.

Catalog No. 50-002-64642 Supplier Medchemexpress LLC Supplier No. HY1090975MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Otaplimastat is a research-grade small-molecule matrix metalloproteinase (MMP) inhibitor supplied as a solid powder for laboratory research. It has molecular formula C28H34N6O5 and a molecular weight of 534.61 g/mol. The material is provided at high purity and is intended for research use only (not for human or veterinary use).

  • High purity (98.1%) suitable for research applications.
  • Molecular weight 534.61 g/mol.
  • Chemical formula C28H34N6O5.
  • Available in small pack sizes, including 5 mg.
  • Supplied as a solid powder for easy handling.
  • Intended for research use only; not for human or veterinary use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.